MARKET COMPOSITE
SELB - Selecta Biosciences Inc
Price
$0.00
+ 0.00 (0.00%)
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation.[failed verification] PacBio describes its platform as single molecule real time sequencing , based on the properties of zero-mode waveguides. The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013. On September 25, 2013 a partnership between Pacific Biosciences and Roche Diagnostics was announced for the development of in vitro diagnostic products using the technology, with Roche providing US$75,000,000 in the deal. In 2015, the company launched a new sequencing instrument called the Sequel System with approximately 7-fold greater capacity than the PacBio RS II. Then in April 2019 the company launched the Sequel II system with a further 8-fold increase in throughput. The company was founded based on research done at Cornell University that combined semiconductor processing and photonics with biotechnology research. Three graduate students in the lab of Professor Harold Craighead — Steve Turner, Jonas Korlach, and Mathieu Foquet — became the first employees.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue8.3MM+26%
Operating Income-36.3MM-
Operating Expenses44.6MM-
Net Income-177.7MM-
R&D22.4MM+73%
G&A22.2MM-
Interest Expense0-100%
Stock Chart
leak data

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news